抗风湿药物的眼部副作用：风湿病医生应该知道什么。
Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.
机构信息
Athens Eye Hospital, Second Eye Clinic, Athens, Greece.
出版信息
Lupus. 2010 May;19(6):675-82. doi: 10.1177/0961203309360539. Epub 2010 Feb 9.
Abstract
Nearly every drug may cause changes to ocular tissues through a variety of mechanisms. Medication overdoses, drug-drug interactions but also chronic administration of medications at the recommended doses may lead to ocular toxicity. The ocular side effects, screening for eye toxicity and treatment guidelines for anti-inflammatory and immunosuppressive drugs commonly used by rheumatologists are reviewed herein.
摘要
几乎每种药物都可能通过多种机制引起眼组织的改变。药物过量、药物相互作用以及推荐剂量下的药物长期使用都可能导致眼毒性。本文回顾了眼科副作用、眼毒性筛查以及风湿科常用的抗炎和免疫抑制剂的治疗指南。
相似文献
1
Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.抗风湿药物的眼部副作用：风湿病医生应该知道什么。
Lupus. 2010 May;19(6):675-82. doi: 10.1177/0961203309360539. Epub 2010 Feb 9.
2
Medical treatment of adolescents with rheumatic disease.青少年风湿性疾病的医学治疗。
Adolesc Med. 1998 Feb;9(1):163-70, vii.
3
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome and the Rheumatologist.药物超敏反应伴嗜酸性粒细胞增多和全身症状（DRESS）综合征与风湿病学家。
Curr Rheumatol Rep. 2017 Jan;19(1):3. doi: 10.1007/s11926-017-0626-z.
4
Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.改善病情抗风湿药：金制剂、青霉胺、抗疟药和柳氮磺胺吡啶。
Curr Opin Rheumatol. 1989 Jun;1(1):74-9. doi: 10.1097/00002281-198901010-00015.
5
Disease-modifying antirheumatic drugs: gold, penicillamine, antimalarials, and sulfasalazine.改善病情抗风湿药：金制剂、青霉胺、抗疟药和柳氮磺胺吡啶。
Curr Opin Rheumatol. 1990 Jun;2(3):489-96. doi: 10.1097/00002281-199002030-00013.
6
Guidelines for use of antirheumatic drugs.抗风湿药物使用指南。
J Rheumatol Suppl. 1994 Sep;41:79-81.
7
Complications of Treatments for Pediatric Rheumatic Diseases.小儿风湿性疾病的治疗并发症
Pediatr Clin North Am. 2018 Aug;65(4):827-854. doi: 10.1016/j.pcl.2018.04.008.
8
Concomitant treatment with nonsteroidal anti-inflammatory drugs and vitamin K antagonists: critical appraisal of the recommendations issued by the French Agency for Healthcare Product Safety.非甾体抗炎药与维生素K拮抗剂的联合治疗：对法国卫生安全局发布建议的批判性评估
Joint Bone Spine. 2001 Dec;68(6):451-3. doi: 10.1016/s1297-319x(01)00306-2.
9
[Not Available].[无可用内容]。
Dtsch Med Wochenschr. 2017 Nov;142(23):1773-1774. doi: 10.1055/s-0043-112255. Epub 2017 Nov 16.
10
Recommendations on the management of adult patients with rheumatic diseases in the context of SARS-CoV-2/COVID-19 infection. Colombian Association of Rheumatology.关于2019冠状病毒病（COVID-19）感染背景下成年风湿性疾病患者管理的建议。哥伦比亚风湿病学会。
Reumatol Clin (Engl Ed). 2020 Nov-Dec;16(6):437-446. doi: 10.1016/j.reuma.2020.06.011. Epub 2020 Jul 28.
引用本文的文献
1
Efficacy and safety of methotrexate in the treatment of proliferative vitreoretinopathy: a systematic review.甲氨蝶呤治疗增殖性玻璃体视网膜病变的疗效与安全性：一项系统评价
Eye (Lond). 2025 Feb;39(3):460-467. doi: 10.1038/s41433-024-03503-5. Epub 2024 Dec 14.
2
Vitamin D ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model via enhancement of the antioxidant defense and minimizing mitochondrial dysfunction.维生素 D 通过增强抗氧化防御和最小化线粒体功能障碍来改善 doxorubicin 心力衰竭大鼠模型中的塞来昔布心脏毒性。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5861-5873. doi: 10.1007/s00210-024-02998-9. Epub 2024 Feb 9.
3
Development and External Validation of a Nomogram for Predicting the Effect of RTX on the Treatment of Membranous Nephropathy.预测利妥昔单抗治疗膜性肾病疗效的列线图的开发与外部验证
J Inflamm Res. 2023 Oct 6;16:4399-4411. doi: 10.2147/JIR.S428218. eCollection 2023.
4
Small Molecule Inhibitors against the Bacterial Pathogen .小分子抑制剂对抗细菌病原体。
Curr Med Chem. 2024;31(27):4267-4285. doi: 10.2174/0929867331666230915153910.
5
Rituximab in patients with membranous nephropathy and kidney insufficiency.利妥昔单抗用于膜性肾病合并肾功能不全患者。
Front Pharmacol. 2022 Oct 10;13:1002117. doi: 10.3389/fphar.2022.1002117. eCollection 2022.
6
Understanding Ocular Findings and Manifestations of Systemic Lupus Erythematosus: Update Review of the Literature.了解系统性红斑狼疮的眼部表现和征象：文献复习更新。
Int J Mol Sci. 2022 Oct 14;23(20):12264. doi: 10.3390/ijms232012264.
7
Potential Ophthalmological Side Effects Induced by Anti-Neoplastic Regimens for the Treatment of Genitourinary Cancers: A Review.用于治疗泌尿生殖系统癌症的抗肿瘤方案引起的潜在眼科副作用：综述
Cureus. 2022 Jul 26;14(7):e27266. doi: 10.7759/cureus.27266. eCollection 2022 Jul.
8
Combination of doxycycline, streptomycin and hydroxychloroquine for short-course treatment of brucellosis: a single-blind randomized clinical trial.多西环素、链霉素和羟氯喹联合短程治疗布鲁氏菌病的单盲随机临床试验。
Infection. 2022 Oct;50(5):1267-1271. doi: 10.1007/s15010-022-01806-x. Epub 2022 Mar 30.
9
A Dose-Response Relationship of Alcohol Consumption with Risk of Visual Impairment in Korean Adults: The Kangbuk Samsung Health Study.饮酒量与韩国成年人视力障碍风险的剂量-反应关系：康伯三星健康研究。
Nutrients. 2022 Feb 14;14(4):791. doi: 10.3390/nu14040791.
10
Natural and iatrogenic ocular manifestations of rheumatoid arthritis: a systematic review.类风湿关节炎的自然和医源性眼部表现：系统评价。
Int Ophthalmol. 2022 Feb;42(2):689-711. doi: 10.1007/s10792-021-02058-8. Epub 2021 Nov 21.
本文引用的文献
1
Edema of cornea precipitated by quinacrine (atabrine).由阿的平（奎纳克林）引起的角膜水肿。
Arch Ophthal. 1946 Feb;35:120-34. doi: 10.1001/archopht.1946.00890200125005.
2
Treatment of lupus nephritis: facing the era of immunotherapy.狼疮性肾炎的治疗：面对免疫治疗时代
Panminerva Med. 2008 Sep;50(3):235-45.
3
Leflunomide-induced toxic epidermal necrolysis in a patient with rheumatoid arthritis.来氟米特诱发的类风湿关节炎患者中毒性表皮坏死松解症
Joint Bone Spine. 2008 Oct;75(5):597-9. doi: 10.1016/j.jbspin.2007.08.013. Epub 2008 Sep 20.
4
Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.阿巴西普治疗儿童幼年特发性关节炎：一项随机、双盲、安慰剂对照撤药试验。
Lancet. 2008 Aug 2;372(9636):383-91. doi: 10.1016/S0140-6736(08)60998-8. Epub 2008 Jul 14.
5
Stevens Johnson syndrome, toxic epidermal necrolysis and SJS-TEN overlap: a retrospective study of causative drugs and clinical outcome.史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症及史蒂文斯-约翰逊综合征-中毒性表皮坏死松解症重叠综合征：致病药物及临床结局的回顾性研究
Indian J Dermatol Venereol Leprol. 2008 May-Jun;74(3):238-40. doi: 10.4103/0378-6323.41369.
6
Chorioretinitis and vitreitis due to Tropheryma whipplei after transplantation: case report and review.移植后由惠普尔嗜组织细胞菌引起的脉络膜视网膜炎和玻璃体炎：病例报告及文献复习
Transpl Infect Dis. 2008 Dec;10(6):413-8. doi: 10.1111/j.1399-3062.2008.00322.x. Epub 2008 Jun 18.
7
Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate.对接受阿巴西普和甲氨蝶呤联合治疗的类风湿性关节炎患者进行的为期两年的随访研究结果。
Arthritis Rheum. 2008 Apr;58(4):953-63. doi: 10.1002/art.23397.
8
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.阿巴西普或英夫利昔单抗对比安慰剂治疗类风湿关节炎（对甲氨蝶呤反应不足）的疗效与安全性：ATTEST一项III期、多中心、随机、双盲、安慰剂对照研究
Ann Rheum Dis. 2008 Aug;67(8):1096-103. doi: 10.1136/ard.2007.080002. Epub 2007 Nov 29.
9
Conjunctival pigmentation in Stevens-Johnson syndrome.史蒂文斯-约翰逊综合征中的结膜色素沉着。
Ann Ophthalmol (Skokie). 2007 Spring;39(2):152-7. doi: 10.1007/s12009-007-0010-0.
10
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy.类风湿关节炎患者对抗肿瘤坏死因子治疗反应不足，接受选择性共刺激调节剂阿巴西普治疗2年后的疗效和安全性。
Ann Rheum Dis. 2008 Apr;67(4):547-54. doi: 10.1136/ard.2007.074773. Epub 2007 Oct 5.
Zotero 插件